NCT00649415 - A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea | Biotech Hunter

Enrollment

154

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2003

Conditions

Dysmenorrhea

Interventions

DRUG

piroxicam

piroxicam 40 mg capsule QD for up to the first 3 days of the menstrual cycle

DRUG

valdecoxib

valdecoxib 40 mg capsule twice a day (BID), taken as required, on the first day of treatment in the menstrual cycle followed by oral valdecoxib 40 mg once a day (QD) for up to the first 3 days of the menstural cycle

Trial Locations (10)

Unknown

Pfizer Investigational Site, Salvador

Pfizer Investigational Site, Goiânia

Pfizer Investigational Site, Porto Alegre

Pfizer Investigational Site, São Paulo

30130-100

Pfizer Investigational Site, Belo Horizonte

30130-110

Pfizer Investigational Site, Belo Horizonte

20551-030

Pfizer Investigational Site, Rio de Janeiro

90610-000

Pfizer Investigational Site, Porto Alegre

04062-003

Pfizer Investigational Site, São Paulo